Pancreatitis panel
Use
The Pancreatitis panel is designed to identify genetic predispositions to pancreatitis. It aims to help alter lifestyle choices, guide management plans, and facilitate risk assessment for family members. Patients with recurrent unexplained attacks of acute pancreatitis, hereditary hyperthyroidism, autoimmune pancreatitis, or unexplained acute pancreatitis episodes, particularly in children or at-risk family members, may benefit from this test. Understanding genetic risk factors can assist in clinical decision-making and personalized patient management.
Special Instructions
Family variant testing is offered at no additional cost for all blood relatives of patients who test positive for a pathogenic or likely pathogenic variant within 90 days of the original report date, provided they are receiving medical care in the U.S or US territories. This service is designed to enhance family-wide risk assessment and management strategies.
Limitations
The Pancreatitis panel, although comprehensive, may not detect all genetic causes of pancreatitis due to limitations in current genetic knowledge and technology. Results may be affected by sample quality or technical issues, and some variants may not be detected due to pseudogene interference or insufficient read depth. Additionally, some pathogenic variants may remain unidentified due to incomplete gene coverage or unknown gene associations with pancreatitis.
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
2-4 weeks
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Blood from patients with a history of allogenic bone marrow or stem cell transplant cannot be used for genetic testing.
Causes for Rejection
Active/recent hematological disease may require alternative specimens like cultured fibroblasts.